Last reviewed · How we verify
Placebo drug of Myonal Tab. — Competitive Intelligence Brief
phase 3
Musculoskeletal/Neurology (as comparator for Myonal)
Small molecule
Live · refreshed every 30 min
Target snapshot
Placebo drug of Myonal Tab. (Placebo drug of Myonal Tab.) — Daewon Pharmaceutical Co., Ltd.. As a placebo, this drug contains no active pharmaceutical ingredient and produces no mechanistic effect beyond the placebo response.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Placebo drug of Myonal Tab. TARGET | Placebo drug of Myonal Tab. | Daewon Pharmaceutical Co., Ltd. | phase 3 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Placebo drug of Myonal Tab. CI watch — RSS
- Placebo drug of Myonal Tab. CI watch — Atom
- Placebo drug of Myonal Tab. CI watch — JSON
- Placebo drug of Myonal Tab. alone — RSS
Cite this brief
Drug Landscape (2026). Placebo drug of Myonal Tab. — Competitive Intelligence Brief. https://druglandscape.com/ci/placebo-drug-of-myonal-tab. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab